Related references
Note: Only part of the references are listed.Differential effects of dual antiplatelet therapy in patients presented with acute coronary syndrome vs. stable ischaemic heart disease after coronary artery bypass grafting
Ki Hong Choi et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2021)
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
Francois Mach et al.
EUROPEAN HEART JOURNAL (2020)
Efficacy and safety of lowering LDL cholesterol in older patients: a systematic review and meta-analysis of randomised controlled trials
Baris Gencer et al.
LANCET (2020)
Intensive versus moderate statin therapy and early graft occlusion after coronary bypass surgery: The Aggressive Cholesterol Therapy to Inhibit Vein Graft Events randomized clinical trial
Alexander Kulik et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2019)
2018 ESC/EACTS Guidelines on myocardial revascularization
Franz-Josef Neumann et al.
EUROPEAN HEART JOURNAL (2019)
Impact of Statins on Cardiovascular Outcomes Following Coronary Artery Calcium Scoring
Joshua D. Mitchell et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
A VOYAGER Meta-Analysis of the Impact of Statin Therapy on Low-Density Lipoprotein Cholesterol and Triglyceride Levels in Patients With Hypertriglyceridemia
Bjorn W. Karlson et al.
AMERICAN JOURNAL OF CARDIOLOGY (2016)
Perioperative Statin Therapy for Patients Undergoing Coronary Artery Bypass Grafting
Amr F. Barakat et al.
ANNALS OF THORACIC SURGERY (2016)
Statin Intensity or Achieved LDL? Practice-based Evidence for the Evaluation of New Cholesterol Treatment Guidelines
Elsie Gyang Ross et al.
PLOS ONE (2016)
Does Pre-Treatment with High Dose Atorvastatin Prevent Microvascular Dysfunction after Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome?
Bong-Ki Lee et al.
KOREAN CIRCULATION JOURNAL (2016)
Secondary Prevention After Coronary Artery Bypass Graft Surgery A Scientific Statement From the American Heart Association
Alexander Kulik et al.
CIRCULATION (2015)
Underutilization of High-Intensity Statin Therapy After Hospitalization for Coronary Heart Disease
Robert S. Rosenson et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Cardiovascular Risk and Statin Use in the United States
Michael Edward Johansen et al.
ANNALS OF FAMILY MEDICINE (2014)
A Prospective Natural-History Study of Coronary Atherosclerosis.
Gregg W. Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Impact of Statin Use on Outcomes After Coronary Artery Bypass Graft Surgery
Alexander Kulik et al.
CIRCULATION (2008)
Intensive lipid-lowering with atorvastatin for secondary prevention in patients after coronary artery bypass surgery
Sanjiv J. Shah et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Pleiotropic effects of statin therapy: molecular mechanisms and clinical results
Chao-Yung Wang et al.
TRENDS IN MOLECULAR MEDICINE (2008)
Patterns and predictors of statin use after coronary artery bypass graft surgery
Alexander Kulik et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2007)
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins
C Baigent et al.
LANCET (2005)
Intensive lipid lowering with atorvastatin in patients with stable coronary disease
JC LaRosa et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvalstaltin, and pravastatin across doses (STELLAR* trial)
PH Jones et al.
AMERICAN JOURNAL OF CARDIOLOGY (2003)
Lovastatin and beyond: The history of the HMG-CoA reductase inhibitors
JA Tobert
NATURE REVIEWS DRUG DISCOVERY (2003)
Share Paper
